Home / Inspections / 1169072

FDA Inspection 1169072 — Cambrex Charles City, Inc.

Cambrex Charles City, Inc. — FEI 1000119390

The FDA completed an inspection of Cambrex Charles City, Inc. on May 2, 2022 in Charles City, IA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 2, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Charles City, IA (United States)

Facility

Other inspections at this facility

  • 1266564 (VAI Fri Mar 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1009802 (VAI Thu Dec 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 868083 (NAI Thu Feb 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 843001 (NAI Fri Aug 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 768805 (NAI Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources